Substantiating the clinical relevance of these findings, increased circulating levels of CXCL10 have been reported in NASH patients compared to in both patients with only steatosis and healthy controls [22]. The gene discussed is CXCL10; the disease is metabolic dysfunction-associated steatohepatitis.